IRAK4 inhibitors (Albany Molecular Research/Merck)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameIRAK4 inhibitors (Albany Molecular Research/Merck)
Drug Alias NameIL-1 receptor-associated kinase 4 inhibitors (Albany Molecular Research/Merck)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-1 receptor-associated kinase 4 inhibitors
TargetsInterleukin-1 receptor-associated kinase 4
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlbany Molecular Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlbany Molecular Research Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A